Comparison of stage at diagnosis of cancer in patients who are on dialysis versus the general population.
OBJECTIVE
Frequent medical encounters in patients with ESRD on dialysis may allow early detection of malignancies despite low rates of cancer screening in this population. It is therefore unclear whether dialysis patients are disadvantaged in terms of cancer diagnosis. This study compared stage at diagnosis of cancer in a population-based sample of patients with ESRD versus the general population.


METHODS
The Surveillance, Epidemiology, and End Results Medicare database was used to identify patients with ESRD and incident cancers from 1992 through 1999. Modified Poisson regression models were used to predict nonlocalized stage of cancer at diagnosis in patients with ESRD versus the general population, adjusting for demographics, cancer site, region, year of diagnosis, and comorbidity. Two general population comparisons were used: Standardized Surveillance, Epidemiology, and End Results public-use data and Medicare control subjects without ESRD matched 3:1 to patients with ESRD.


RESULTS
A total of 1629 patients with ESRD and incident cancer were identified. Overall, the likelihood of nonlocalized stage at diagnosis was not significantly different for patients with ESRD versus the standardized Surveillance, Epidemiology, and End Results general population or matched Medicare control subjects. Stratifying by cancer site, colorectal cancers were significantly more likely to be diagnosed earlier in the ESRD group, whereas prostate cancers were significantly more likely to be diagnosed at a later stage.


CONCLUSIONS
With the exception of prostate cancer, patients with ESRD are not more likely to present with later stage malignancies compared with the general population.
Taneja
Shilpa
S
Department of Internal Medicine, University of Texas Medical Branch, Galveston, Texas, USA.
Mandayam
Sreedhar
S
Kayani
Zainab Z
ZZ
Kuo
Yong-Fang
YF
Shahinian
Vahakn B
VB
D000368:Aged; D005260:Female; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications* / Q000628:therapy; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D009369:Neoplasms / Q000150:complications* / Q000175:diagnosis*; D006435:Renal Dialysis
CA Cancer J Clin. 2006 Jan-Feb;56(1):11-25; quiz 49-50
16449183
J Gen Intern Med. 2005 Jan;20(1):38-44
15693926
Ann Surg Oncol. 2004 Nov;11(11):962-9
15525824
J Natl Cancer Inst. 1999 Aug 18;91(16):1409-15
10451447
Lancet. 1999 Jul 10;354(9173):93-9
10408483
JAMA. 1998 Sep 16;280(11):975-80
9749479
N Engl J Med. 1998 Sep 17;339(12):799-805
9738087
Am J Med Sci. 1998 Aug;316(2):94-104
9704663
Arch Intern Med. 1996 Jun 24;156(12):1345-50
8651845
N Engl J Med. 1996 Feb 15;334(7):420-5
8552143
Med Care. 1993 Aug;31(8):732-48
8336512
Artif Organs. 1990 Apr;14(2):95-7
2350261
J Chronic Dis. 1987;40(5):373-83
3558716
Ann Intern Med. 1985 May;102(5):588-92
3872616
Thorax. 2004 Jul;59(7):602-7
15223870
Am J Epidemiol. 2004 Apr 1;159(7):702-6
15033648
J Am Soc Nephrol. 2003 Apr;14(4):1099-101
12660346
J Gen Intern Med. 2002 Aug;17(8):588-95
12213139
Med Care. 2002 Aug;40(8 Suppl):IV-3-18
12187163
J Am Soc Nephrol. 2001 Jun;12(6):1293-6
11373354
J Clin Epidemiol. 2000 Dec;53(12):1258-67
11146273
Semin Dial. 2000 Nov-Dec;13(6):369-71
11130258
JAMA. 2006 Dec 20;296(23):2823-31
17179459
Adv Perit Dial. 2000;16:93-6
11045269
Int J Urol. 2000 Dec;7(12):464-6
11168686
Cochrane Database Syst Rev. 2006;(3):CD004720
16856057
Am J Kidney Dis. 2000 Feb;35(2):237-43
10676722
Am J Kidney Dis. 2000 Feb;35(2):347-51; discussion 352-3
10676739
Lancet. 2000 May 27;355(9218):1886-7
10866449